Form 8-K dated December 17, 2002
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported) December 17, 2002
Targeted Genetics Corporation
(Exact name of registrant as specified in charter)
| Washington |
|
0-23930 |
|
91-1549568 |
| (State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
| of incorporation) |
|
File Number) |
|
Identification No.) |
| 1100 Olive Way, Suite 100, Seattle, Washington |
|
98101 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone
number, including area code (206) 623-7612
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
On December 17, 2002, Targeted Genetics Corporation announced that it is initiating a strategic adjustment to its business strategy in order to best leverage its most
promising product development opportunities and to extend its operating capital. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference.
Item 7. Exhibits.
(a) Financial statements of business acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c)
Exhibits.
| Exhibit No.
|
|
Description
|
| |
| 99.1 |
|
Press Release dated December 17, 2002 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
TARGETED GENETICS CORPORATION |
| |
| Date: December 17, 2002 |
|
|
|
By: |
|
/s/ TODD E. SIMPSON
|
| |
|
|
|
|
|
|
|
Vice President, Finance and Administration and Chief Financial Officer, Secretary and
Treasurer (Principal Financial and Accounting Officer) |
EXHIBIT INDEX
| Exhibit No.
|
|
Description
|
| |
| 99.1 |
|
Press Release dated December 17, 2002 |